Extendicare (EXE) Earnings Date, Estimates & Call Transcripts → 4 Cryptos BETTER than Bitcoin (From True Market Insiders) (Ad) Free EXE Stock Alerts C$7.31 +0.05 (+0.69%) (As of 02:38 PM ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsHeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsHeadlines Earnings SummaryUpcoming Earnings DateMay. 15After Market ClosesConfirmedActual EPS (Mar. 7) C$0.10 Beat By C$0.10 Get Extendicare Earnings AlertsEnter your email address below to receive the latest news and earnings results for EXE and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueEXE Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.EXE Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad The Bull ReportHealthcare Takes A Big Step Forward With The Help Of AIThe average doctor can diagnose an illness correctly 50-90% of the time. But one innovative company's medical AI gets it right 92%+.Click here to see why this small company is trusted by the Mayo Clinic Extendicare Analyst EPS EstimatesCurrent Year EPS Consensus Estimate:C$0.39 EPSEXE Earnings Date and InformationExtendicare last released its earnings data on March 7th, 2024. The reported C$0.10 EPS for the quarter. The company had revenue of C$350.18 million for the quarter. Extendicare has generated C$0.40 earnings per share over the last year (C$0.40 diluted earnings per share) and currently has a price-to-earnings ratio of 18.3. Extendicare has confirmed that its next quarterly earnings report will be published on Wednesday, May 15th, 2024. Read More Extendicare Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 5/15/2024Confirmed)------- 3/7/2024Q4 2023-C$0.10+C$0.10C$0.10-C$350.18 million11/9/2023Q3 2023-C$0.14+C$0.14C$0.14-C$322.53 million8/10/2023Q2 2023C$0.08C$0.02C($0.06)C$0.02-C$307.54 million5/4/2023Q1 2023C$0.06C$0.14+C$0.08C$0.14C$299.70 millionC$324.71 million3/2/2023Q4 2022C$0.05C($0.08)C($0.13)C($0.14)C$309.50 millionC$310.39 million11/10/2022Q3 2022C$0.03C$0.04+C$0.01C$0.04C$312.80 millionC$308.89 million Get the Latest News and Ratings for EXE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Extendicare and its competitors with MarketBeat's FREE daily newsletter. 8/9/2022Q2 2022C$0.05C$0.04C($0.01)C($0.64)C$308.10 millionC$296.59 million5/12/2022Q1 2022C$0.11C$0.04C($0.07)C$0.04C$314.50 millionC$305.71 million2/24/2022Q4 2021-C($0.05)C($0.05)C($0.06)-C$319.37 million11/4/2021Q3 2021C$0.11C$0.03C($0.08)C($0.01)C$305.80 millionC$310.13 million8/5/2021Q2 2021C$0.06C$0.01C($0.05)C$0.01C$307.40 millionC$307.45 million5/12/2021Q1 2021C$0.15C$0.09C($0.06)C$0.09C$306.90 millionC$322.38 million Extendicare Earnings - Frequently Asked Questions When is Extendicare's earnings date? Extendicare has confirmed that its next quarterly earnings data will be published on Wednesday, May 15th, 2024. Learn more on EXE's earnings history. How much revenue does Extendicare generate each year? Extendicare (TSE:EXE) has a recorded annual revenue of C$1.30 billion. How much profit does Extendicare generate each year? Extendicare (TSE:EXE) has a recorded net income of C$33.98 million. EXE has generated C$0.40 earnings per share over the last four quarters. What is Extendicare's price-to-earnings ratio? Extendicare (TSE:EXE) has a trailing price-to-earnings ratio of 18.25 and a forward price-to-earnings ratio of 18.93. More Earnings Resources from MarketBeat Related Companies: DR Earnings Results SIA Earnings Results GUD Earnings Results ACB Earnings Results VMD Earnings Results FRX Earnings Results OPS Earnings Results KSI Earnings Results VHI Earnings Results OGI Earnings Results Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: GE Aerospace is Ready for Liftoff After Strong EarningsTaiwan Semiconductor Earnings: AI Dominance and Future OutlookCSX Co.: The Railroad Powering Ahead with an Earnings Beat What's Driving Tesla Lower Ahead of its Earnings?Blackrock vs. State Street: Earnings in a Volatile MarketWhat to Expect From the Q1 Earnings Reporting SeasonLululemon Stock Implodes Post Earnings, Guidance Muted This page (TSE:EXE) was last updated on 4/29/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingThe #1 Biotech Stock to Have on Your Radar in 2024… Huge AlertsAI finds its first serious applicationWall Street StarHave You Seen Elon’s New A.I. Device? (Picture Inside)InvestorPlaceHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportHe Is Giving Away BitcoinCrypto Swap ProfitsForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Extendicare Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
